Roland J. Fuchs

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele et al. · Leukemia · 2017 · 339 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986

Claus Henning Köhne, Eric Van Cutsem, J. Wils et al. · Journal of Clinical Oncology · 2005 · 329 citations

Medicine, Oncology, Pharmacotherapy +16

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

Christian Buske, Eva Hoster, Martin Dreyling et al. · Leukemia · 2008 · 155 citations

Medicine, Oncology, Immuno-oncology Pharmacotherapy +5

Secondary Cities in Developing Countries: Policies for Diffusing Urbanization

Roland J. Fuchs, Dennis A. Rondinelli · Economic Geography · 1983 · 120 citations

Social Sciences, Urban Planning, Urban Policy +17

Climate Change and Asia’s Coastal Urban Cities

Roland J. Fuchs, Mary Conran, Elizabeth Louis · Environment and Urbanization Asia · 2011 · 93 citations

Natural Sciences, Earth Sciences, Climate Science +16